{
    "clinical_study": {
        "@rank": "18334", 
        "arm_group": [
            {
                "arm_group_label": "70% VO2max", 
                "arm_group_type": "Experimental", 
                "description": "Cognitive Behavioural Therapy (CBT)\n+ aerobic exercise (30 minutes, 70% VO2max) prior to 5 in-vivo exposure sessions"
            }, 
            {
                "arm_group_label": "30% VO2max", 
                "arm_group_type": "Active Comparator", 
                "description": "Cognitive Behavioural Therapy (CBT)\n+ placebo exercise (30 minutes, 30% VO2max) prior to 5 in-vivo exposure sessions"
            }
        ], 
        "brief_summary": {
            "textblock": "Physical activity (treadmill) prior to in-vivo exposure supports the effect of cognitive\n      behavioural therapy in patients with panic disorder and agoraphobia."
        }, 
        "brief_title": "Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Panic Disorder", 
            "Agoraphobia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Agoraphobia", 
                "Panic Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients receive a 12-session manualized cognitive behavioural therapy, implemented over 7\n      weeks and followed by two booster sessions. Five sessions consist of in-vivo exposures.\n      Prior to these sessions patients undergo a training of physical activity. Half of the\n      patients complete training on a treadmill at 70% of their maximal oxygen uptake while the\n      other half complete training at 30%."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject familiarized with experimental procedure and had given written informed\n             consent\n\n          -  Diagnosis of panic disorder with agoraphobia according to Diagnostic and Statistical\n             Manual of Mental Disorders (DSM-IV)\n\n          -  Score >= 18 in Hamilton Rating Scale for Anxiety\n\n          -  Score >= 4 in Clinical Global Index\n\n          -  Reachability of patient for treatment and follow-up\n\n        Exclusion Criteria:\n\n          -  DSM-IV Axis I diagnoses of any psychotic disorder, bipolar disorder, current alcohol\n             or drug dependence and Axis II borderline personality disorder\n\n          -  Change in pharmacological treatment in the last 4 weeks\n\n          -  Acute suicidality\n\n          -  Medical contraindications for mild to moderate exercise training or exposure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "78", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928810", 
            "org_study_id": "201015"
        }, 
        "intervention": {
            "arm_group_label": [
                "70% VO2max", 
                "30% VO2max"
            ], 
            "description": "12 sessions of CBT including psychoeducation, interoceptive exposure and in-vivo exposure", 
            "intervention_name": "Cognitive Behavioural Therapy", 
            "intervention_type": "Behavioral", 
            "other_name": "CBT"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Panic Disorder", 
            "Agoraphobia", 
            "Physical Activity"
        ], 
        "lastchanged_date": "February 14, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.angstambulanz-charite.de/"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Influence of Physical Activity (Prior to In-vivo Exposure) on the Effect of Cognitive Behavioural Therapy in Patients With Panic Disorder and Agoraphobia", 
        "overall_official": {
            "affiliation": "Charite", 
            "last_name": "Sophie Bischoff, Dipl.-Psych.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Global interviewer rated measure for anxiety and severity indicator of an anxiety disorder", 
                "measure": "Hamilton Rating Scale for Anxiety (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to 31 weeks (follow-up)"
            }, 
            {
                "description": "A 27-item inventory for the measurement of self-reported agoraphobic avoidance behavior", 
                "measure": "Mobility Inventory (Chambless 1984)", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline to 31 weeks (follow-up)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928810"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Charite University, Berlin, Germany", 
            "investigator_full_name": "Prof. Dr. Andreas Str\u00f6hle", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Clinical Global Index (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)"
            }, 
            {
                "measure": "Beck Depression Inventory (CIPS 1995)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)"
            }, 
            {
                "measure": "Anxiety Sensitivity Index (Taylor 1998)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, every second session, 3 weeks, 7 weeks, 31 weeks (follow up)"
            }, 
            {
                "measure": "Body Sensations Questionnaire (Chambless 1984)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)"
            }, 
            {
                "measure": "Agoraphobic Cognitions Questionaire (Chambless 1984)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 weeks, 7 weeks, 31 weeks (follow up)"
            }, 
            {
                "description": "Severity scale for panic disorder", 
                "measure": "Panic and Agoraphobia Scale", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to 31 weeks (follow-up)"
            }
        ], 
        "source": "Charite University, Berlin, Germany", 
        "sponsors": {
            "collaborator": {
                "agency": "German Federal Ministry of Education and Research", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Charite University, Berlin, Germany", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}